BNCT has shown promise in treating various types of cancer, particularly those that are difficult to manage with conventional therapies. These include glioblastoma multiforme, a highly aggressive brain tumor, and recurrent head and neck cancers. Researchers are also exploring its potential in treating melanoma, liver cancer, and other malignancies. The selective targeting capability of BNCT makes it a valuable option for tumors located in sensitive or critical areas.